InvestorsHub Logo
Followers 14
Posts 456
Boards Moderated 0
Alias Born 04/07/2013

Re: 67stang post# 25183

Saturday, 02/08/2014 7:14:49 PM

Saturday, February 08, 2014 7:14:49 PM

Post# of 427445
67stang - They did not "ask for it" meaning they did not say to the FDA "we want our label to say we are treating CVE's...

It is Amarin's goal as a company.

The FDA took note of this subtle unintentional point and said: Can't happen.

Now if their application did not mention it what would have happened?

Maybe the same exact thing because there is no "proven benefit" of treating Trigs below 500 right now.

That is where the FDA is caught in the middle: The world says there is yet no one has proven it.

So what is the easiest way out: "Prove it"...

(Remember this is part of thew "new and improved FDA"...)

That test is called: Reduce-It


Why all of the hype: We hear a million commercials with "Side Effects" the length of our arms and cannot wrap our heads around the fact that "Fish Oil" is being rejected - I being one of them!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News